Molecular formula: C7H9N Molecular weight: 107.17
N-Methylaniline was studied for oral toxicity in rats in a single dose toxicity test at doses of 0, 512, 1024, 640, 800, 1000 and 2000 mg/kg and in a 28-day repeat dose toxicity test at doses of 0, 5, 25 and 125 mg/kg. Genotoxicity of N-methylaniline was also studied by the reverse mutation assay in bacteria and the chromosomal aberration test in cultured Chinese hamster lung (CHL/IU) cells.
The single dose toxicity test revealed LD50 values of 782 mg/kg for males and of 716 mg/kg for females.
In the 28-day repeat dose toxicity test, methemoglobinemia was induced by the administration of N-methylaniline. Cyanosis, anemia and yellowish brown urine were observed in both sexes receiving 25 or 125 mg/kg. Absolute and relative spleen weights increased in both sexes given the 125 mg/kg dose and females of the 25 mg/kg groups.
Macroscopically, enlargement and black change of the liver were observed in both sexes given 25 or 125 mg/kg. Histopathologically, congestion, increase in hematopoiesis or deposition of pigment in the spleen, increase in hematopoiesis in the bone marrow, extramedullary hematopoiesis and deposits of pigment in the liver and proximal tubules of the kidney were observed in treated groups of both sexes. The NOELs are considered to be 5 mg/kg for both sexes.
N-Methylaniline was not mutagenic in Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA.
Structural chromosomal aberrations were induced at the highest (10 mM = 1.1 mg/ml) and the mid (0.6 mg/ml) concentrations after continuous 24- and 48-hr treatments. In the presence of exogenous metabolic activation, structural chromosomal aberrations were also induced at the highest concentration (1.1 mg/ml). Polyploid cells were not induced under the present experimental conditions.
Purity | : | 99.4% |
Test species/strains | : | Rats/Crj: CD (SD) |
Test method | : | OECD Test Guideline 401 |
Route | : | Oral (gavage) |
Dosage | : | 512, 640, 800, 1000, 1250 mg/kg |
Number of animals | : | Males, 5; females, 5/group |
Vehicle | : | Corn oil |
GLP | : | Yes |
Test results | : | LD50: males, 782 mg/kg; females, 716 mg/kg |
Purity | : | 99.4% |
Test species/strain | : | Rats/Crj:CD (SD) |
Test method | : | Guidelines for 28-day Repeated Dose Toxicity Testing of Chemicals (Japan) |
Route | : | Oral |
Dosage | : | 0 (vehicle), 5, 25, 125 mg/kg/day |
Vehicle | : | Corn oil |
Number of animals | : | Males, 5; females, 5/group |
Administration period | : | Males and females, 28 days |
Terminal kill | : | Males and females, days 29 to 43 |
GLP | : | Yes |
Test results:
Purity | : | 99.5% |
Test species/strains | : | S.typhimurium TA100, TA1535, TA98, TA1537 E. coli WP2 uvrA |
Test methods | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Procedures | : | Plate incorporation method |
Solvent | : | DMSO -S9 Mix, AF-2 (TA100, WP2, TA98), sodium azide (TA1535) and 9-aminoacridine (TA1537) +S9 Mix, 2-aminoanthracene (all strains) |
Doses | : | -S9 Mix: 0, 156.3, 312.5, 625, 1250, 2500. 5000 μg/plate |
+S9 Mix: 0, 312.5, 625, 1250, 2500, 5000 μg/plate | ||
S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 3 |
Number of replicates | : | 2 |
GLP | : | Yes |
+ | ? | - | |
without metabolic activation: | [ ] | [ ] | [*] |
with metabolic activation: | [ ] | [ ] | [*] |
+ | ? | - | |
without metabolic activation: | [ ] | [ ] | [*] |
with metabolic activation: | [ ] | [ ] | [*] |
Purity | : | 99.5% |
Type of cell used | : | Chinese hamster lung (CHL/IU) cells |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Solvent | : | Dimethyl sulfoxide |
Positive controls | : | -S9, Mitomycin C +S9, Cyclophosphamide |
Doses | : | -S9 (continuous treatment): 0, 0.3, 0.6, 1.1 mg/ml -S9 (short-term treatment): 0, 0.3, 0.6, 1.1 mg/ml +S9 (short-term treatment): 0, 0.3, 0.6, 1.1 mg/ml |
S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 2 |
GLP | : | Yes |
clastogenicity | polyploidy | |||||
+ | ? | - | + | ? | - | |
without metabolic activation: | [*] | [ ] | [ ] | [ ] | [ ] | [*] |
with metabolic activation: | [*] | [ ] | [ ] | [ ] | [ ] | [*] |
1) | The tests were performed by the Biosafety Research Center, Foods, Drugs and Pesticides (An-pyo Center), Japan, 582-2 Shioshinden Arahama, Fukude-cho, Iwata-gun, Shizuoka, 437-12, Japan. Tel 81-538-58-1266 Fax 81-538-58-1393 |
2) | The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa, 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627 |